Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ritzel

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Diabetes Care|June 14, 2018
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR StudyRobert Ritzel, Stewart B Harris, Helen Baron, et al.
Diabetes Care|August 15, 2018
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT TrialJulio Rosenstock, Alice Cheng, Robert Ritzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66ShcFabian Bock, Khurrum Shahzad, Hongjie Wang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Diabetes Care|June 14, 2018
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR StudyRobert Ritzel, Stewart B Harris, Helen Baron, et al.
Diabetes Care|August 15, 2018
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT TrialJulio Rosenstock, Alice Cheng, Robert Ritzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66ShcFabian Bock, Khurrum Shahzad, Hongjie Wang, et al.
Pageof 2